D
CRISPR Therapeutics AG CRSP
$54.13 -$0.19-0.35% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -467.80M -385.66M -366.25M -239.59M -265.80M
Total Depreciation and Amortization 18.97M 19.16M 19.26M 19.32M 19.50M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 150.44M 59.39M 47.95M 54.81M 54.97M
Change in Net Operating Assets -26.37M 628.00K 156.27M -23.35M 69.57M
Cash from Operations -324.77M -306.47M -142.77M -188.82M -121.76M
Capital Expenditure -796.00K -1.39M -1.90M -2.39M -4.28M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -4.76M -201.05M -278.58M -465.38M -180.53M
Cash from Investing -5.55M -202.44M -280.48M -467.76M -184.81M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 39.36M 37.10M 332.45M 354.51M 346.43M
Repurchase of Common Stock -- -466.00K -466.00K -466.00K -466.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 39.36M 36.64M 331.98M 354.05M 345.96M
Foreign Exchange rate Adjustments 109.00K 31.00K -21.00K 127.00K 4.00K
Miscellaneous Cash Flow Adjustments -- -- -- -1.00K -1.00K
Net Change in Cash -290.85M -472.24M -91.29M -302.41M 39.40M